Literature DB >> 16758100

Endobronchial pulmonary nocardiosis.

Neena Kumar1, Raji Ayinla.   

Abstract

In recent years, the reported incidence of nocardiosis, a localized or disseminated infection caused by Nocardia, has been increasing. This increase can be attributed to the improvements in diagnostic capabilities and the higher clinical index of suspicion, as well as the increased prevalence of immunosuppressed patients. We report a case of pulmonary nocardiosis in a healthy young female who presented with cough and hemoptysis, which persisted even after empiric treatment for pulmonary tuberculosis. CT scan of her chest showed infiltrates in the right upper, middle and lower lobes with pleural effusion. Bronchoscopy revealed a friable endobronchial mass. Special stains confirmed the diagnosis of nocardiosis. The patient's symptoms and clinical findings improved with trimethoprim-sulfamethoxazole. To the best of our knowledge, this is the fourth case of this illness presenting as endobronchial mass reported in the literature. Pulmonary nocardiosis should be considered in the differential diagnosis of hemoptysis, even in immunocompetent patients.

Entities:  

Mesh:

Year:  2006        PMID: 16758100

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN: 0027-2507


  3 in total

Review 1.  Infections causing central airway obstruction: role of bronchoscopy in diagnosis and management.

Authors:  Sevak Keshishyan; Lawrence DeLorenzo; Kassem Hammoud; Arpine Avagyan; Hussein Assallum; Kassem Harris
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

2.  Endobronchial Enigma: A Clinically Rare Presentation of Nocardia beijingensis in an Immunocompetent Patient.

Authors:  Nader Abdel-Rahman; Shimon Izhakian; Walter G Wasser; Oren Fruchter; Mordechai R Kramer
Journal:  Case Rep Pulmonol       Date:  2015-12-24

3.  Specific clinical manifestations of Nocardia: A case report and literature review.

Authors:  Songsong Yu; Jing Wang; Qiuhong Fang; Jixin Zhang; Fengcai Yan
Journal:  Exp Ther Med       Date:  2016-08-04       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.